 Hoth Therapeutics Inc NASDAQ: HOTH has initiated its preclinical study utilizing Hoths HT-ALZ in an animal model. The study aims to determine the effects of HT-ALZ on behavioral and pathological markers of Alzheimers disease and determine if HT-ALZ can improve learning and memory in an animal model of Alzheimers disease. 